NOVEL GLUCOPYRANOSE ESTERS AND GLUCOFURANOSE ESTERS OF ALKYL FUMARATES AND THEIR PHARMACEUTICAL USE

Jens E.T. Andersen (Inventor), Henrik Nilsson (Inventor)

Research output: Patent

Abstract

The present invention relates to novel glucofuranose esters
and glucopyranose esters of alkyl-fumarates. The esters are
suitable for use as active substances in the treatment of e.g.
psoriasis or other hyperproliferative, in?ammatory or
autoimmune disorders.
Original languageEnglish
Patent numberUS 2010/0144651 A1
Filing date7/7/06
Publication statusPublished - Jun 10 2010

Fingerprint

Fumarates
Esters
Patents and inventions
Pharmaceutical Preparations

Cite this

@misc{c747e61eea4e4d4abed0d9de561dedf3,
title = "NOVEL GLUCOPYRANOSE ESTERS AND GLUCOFURANOSE ESTERS OF ALKYL FUMARATES AND THEIR PHARMACEUTICAL USE",
abstract = "The present invention relates to novel glucofuranose estersand glucopyranose esters of alkyl-fumarates. The esters aresuitable for use as active substances in the treatment of e.g.psoriasis or other hyperproliferative, in?ammatory orautoimmune disorders.",
author = "Andersen, {Jens E.T.} and Henrik Nilsson",
year = "2010",
month = "6",
day = "10",
language = "English",
type = "Patent",
note = "US 2010/0144651 A1",

}

NOVEL GLUCOPYRANOSE ESTERS AND GLUCOFURANOSE ESTERS OF ALKYL FUMARATES AND THEIR PHARMACEUTICAL USE. / Andersen, Jens E.T. (Inventor); Nilsson, Henrik (Inventor).

Patent No.: US 2010/0144651 A1. Jul 07, 2006.

Research output: Patent

TY - PAT

T1 - NOVEL GLUCOPYRANOSE ESTERS AND GLUCOFURANOSE ESTERS OF ALKYL FUMARATES AND THEIR PHARMACEUTICAL USE

AU - Andersen, Jens E.T.

AU - Nilsson, Henrik

PY - 2010/6/10

Y1 - 2010/6/10

N2 - The present invention relates to novel glucofuranose estersand glucopyranose esters of alkyl-fumarates. The esters aresuitable for use as active substances in the treatment of e.g.psoriasis or other hyperproliferative, in?ammatory orautoimmune disorders.

AB - The present invention relates to novel glucofuranose estersand glucopyranose esters of alkyl-fumarates. The esters aresuitable for use as active substances in the treatment of e.g.psoriasis or other hyperproliferative, in?ammatory orautoimmune disorders.

M3 - Patent

M1 - US 2010/0144651 A1

Y2 - 2006/07/07

ER -